Growth Metrics

Nexgel (NXGL) Long-Term Investments (2025)

Nexgel posted quarterly Long-Term Investments of $249000.0 for Q4 2025.

Nexgel (NXGL) has 1 years of Long-Term Investments data on file, last reported at $249000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Long-Term Investments changed N/A year-over-year to $249000.0; the trailing twelve-month figure through Dec 2025 stood at $249000.0 (changed N/A YoY), and the FY2025 full-year result was $249000.0, changed N/A from the prior year.
  • Long-Term Investments for Q4 2025 stood at $249000.0.
  • Across five years, Long-Term Investments topped out at $249000.0 in Q4 2025 and bottomed at $249000.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 3.46 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn -
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 209.20 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn -
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn -
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 130.76 Mn
10 Nexgel 31,199.58 -1.34 Mn 819,000.00 249,000.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 249,000.00